Lack of Antilipoprotein Lipase Antibodies in Takayasu's Arteritis

Table 1

Demographic, clinical features and prednisone use of patients with Takayasu’s arteritis. Values are expressed in mean ± SD or percentage (%).

	Takayasu’s arteritis (𝑛=30)
Age (years)	33.8±8.1
White race, 𝑛 (%)	21 (70)
Body mass index (kg/m^2)	25.5±5.5
Disease duration (years)	6.7±6.9
Prednisone use, 𝑛 (%)	17 (56.6)
Current prednisone dose (mg/day)	9.7±13.7
Systemic arterial hypertension, 𝑛 (%)	24 (80)